In the present study, we demonstrated that NAFLD and, furtherly, the more severe NASH, lead to brain dysfunction characterized by a modulation of BA receptors FXR and TGR5. The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatohepatitis.